Literature DB >> 33750208

The Open Vein Hypothesis and Postthrombotic Syndrome: Not Dead Yet.

Aaron W Aday1, Joshua A Beckman1.   

Abstract

Entities:  

Keywords:  Editorials; fibrosis; inflammation; postthrombotic syndrome; thrombosis; venous thromboembolism

Mesh：

Year:  2021        PMID： 33750208      PMCID： PMC7989011          DOI： 10.1161/CIRCULATIONAHA.120.052451

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  14 in total

1.  Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months.

Authors:  S Schulman; P Lindmarker; M Holmström; G Lärfars; A Carlsson; P Nicol; E Svensson; B Ljungberg; S Viering; S Nordlander; B Leijd; K Jahed; M Hjorth; O Linder; M Beckman
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

2.  Postthrombotic morbidity correlates with residual thrombus following catheter-directed thrombolysis for iliofemoral deep vein thrombosis.

Authors:  Anthony J Comerota; Nina Grewal; Jorge Trabal Martinez; John Tahao Chen; Robert Disalle; Linda Andrews; Deb Sepanski; Zakaria Assi
Journal:  J Vasc Surg       Date:  2012-01-24       Impact factor: 4.268

Review 3.  Chronic venous disease.

Authors:  John J Bergan; Geert W Schmid-Schönbein; Philip D Coleridge Smith; Andrew N Nicolaides; Michel R Boisseau; Bo Eklof
Journal:  N Engl J Med       Date:  2006-08-03       Impact factor: 91.245

4.  Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis.

Authors:  Anthony J Comerota; Clive Kearon; Chu-Shu Gu; Jim A Julian; Samuel Z Goldhaber; Susan R Kahn; Michael R Jaff; Mahmood K Razavi; Andrei L Kindzelski; Riyaz Bashir; Parag Patel; Mel Sharafuddin; Michael J Sichlau; Wael E Saad; Zakaria Assi; Lawrence V Hofmann; Margaret Kennedy; Suresh Vedantham
Journal:  Circulation       Date:  2019-02-26       Impact factor: 29.690

5.  Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.

Authors:  Tone Enden; Ylva Haig; Nils-Einar Kløw; Carl-Erik Slagsvold; Leiv Sandvik; Waleed Ghanima; Geir Hafsahl; Pål Andre Holme; Lars Olaf Holmen; Anne Mette Njaastad; Gunnar Sandbæk; Per Morten Sandset
Journal:  Lancet       Date:  2011-12-13       Impact factor: 79.321

Review 6.  Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based systematic review.

Authors:  M H Pittler; E Ernst
Journal:  Arch Dermatol       Date:  1998-11

7.  Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis.

Authors:  L W Tick; M H H Kramer; F R Rosendaal; W R Faber; C J M Doggen
Journal:  J Thromb Haemost       Date:  2008-10-04       Impact factor: 5.824

8.  Residual rates of reflux and obstruction and their correlation to post-thrombotic syndrome in a randomized study on catheter-directed thrombolysis for deep vein thrombosis.

Authors:  Ylva Haig; Tone Enden; Carl-Erik Slagsvold; Leiv Sandvik; Per Morten Sandset; Nils Einar Kløw
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2014-01-16

9.  Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects.

Authors:  Wenzhu Li; Chase W Kessinger; Makoto Orii; Hang Lee; Lang Wang; Ido Weinberg; Michael R Jaff; Guy L Reed; Peter Libby; Ahmed Tawakol; Peter K Henke; Farouc A Jaffer
Journal:  Circulation       Date:  2021-01-15       Impact factor: 29.690

10.  Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.

Authors:  Suresh Vedantham; Samuel Z Goldhaber; Jim A Julian; Susan R Kahn; Michael R Jaff; David J Cohen; Elizabeth Magnuson; Mahmood K Razavi; Anthony J Comerota; Heather L Gornik; Timothy P Murphy; Lawrence Lewis; James R Duncan; Patricia Nieters; Mary C Derfler; Marc Filion; Chu-Shu Gu; Stephen Kee; Joseph Schneider; Nael Saad; Morey Blinder; Stephan Moll; David Sacks; Judith Lin; John Rundback; Mark Garcia; Rahul Razdan; Eric VanderWoude; Vasco Marques; Clive Kearon
Journal:  N Engl J Med       Date:  2017-12-07       Impact factor: 176.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.